$THRY
Thryv Holdings Inc

2020 Q4 Form 10-Q Financial Statement

#000162828020016327 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $1.784B $240.3M $319.1M
YoY Change -24.69%
Cost Of Revenue $87.80M $105.4M
YoY Change
Gross Profit $159.2M $134.9M
YoY Change
Gross Profit Margin 8.92% 56.12%
Selling, General & Admin $99.50M $112.3M $118.1M
YoY Change -4.89%
% of Gross Profit 62.5% 83.26%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $35.60M $35.50M
YoY Change -64.93%
% of Gross Profit 22.36% 26.32%
Operating Expenses $135.1M $112.3M $118.1M
YoY Change -4.89%
Operating Profit $24.10M $21.39M $40.92M
YoY Change -47.72%
Interest Expense -$15.00M $15.61M $23.67M
YoY Change -34.04%
% of Operating Profit -62.24% 72.98% 57.84%
Other Income/Expense, Net -$10.90M -$1.105M $410.0K
YoY Change -369.51%
Pretax Income -$8.500M -$24.40M $1.138M
YoY Change -2243.67%
Income Tax -$118.3M -$24.25M $1.410M
% Of Pretax Income 123.9%
Net Earnings $109.8M -$145.0K -$272.0K
YoY Change -46.69%
Net Earnings / Revenue 6.15% -0.06% -0.09%
Basic Earnings Per Share $0.00 -$0.01
Diluted Earnings Per Share $3.307M $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 31.03M shares 30.86M shares 33.47M shares
Diluted Shares Outstanding 30.86M shares 33.47M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.400M $1.800M
YoY Change
Cash & Equivalents $2.406M $1.771M $2.184M
Short-Term Investments
Other Short-Term Assets $12.76M $55.90M
YoY Change
Inventory
Prepaid Expenses
Receivables $296.6M $326.2M
Other Receivables $9.300M $27.80M
Total Short-Term Assets $369.7M $424.2M
YoY Change -22.75%
LONG-TERM ASSETS
Property, Plant & Equipment $89.04M $86.43M
YoY Change -12.28%
Goodwill $609.5M $609.5M
YoY Change 0.0%
Intangibles $31.78M $60.56M
YoY Change -78.45%
Long-Term Investments
YoY Change
Other Assets $21.90M $10.58M
YoY Change -57.28%
Total Long-Term Assets $845.3M $789.8M
YoY Change -7.08%
TOTAL ASSETS
Total Short-Term Assets $369.7M $424.2M
Total Long-Term Assets $845.3M $789.8M
Total Assets $1.215B $1.214B
YoY Change -12.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.927M $16.22M
YoY Change -44.44%
Accrued Expenses $139.6M $165.9M
YoY Change -0.46%
Deferred Revenue $18.94M $18.77M
YoY Change -23.25%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $700.0K
YoY Change
Total Short-Term Liabilities $207.4M $249.7M
YoY Change -19.44%
LONG-TERM LIABILITIES
Long-Term Debt $528.4M $640.8M
YoY Change
Other Long-Term Liabilities $36.27M $623.0K
YoY Change -57.53%
Total Long-Term Liabilities $810.8M $927.5M
YoY Change -26.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $207.4M $249.7M
Total Long-Term Liabilities $810.8M $927.5M
Total Liabilities $1.018B $1.177B
YoY Change -25.19%
SHAREHOLDERS EQUITY
Retained Earnings -$394.8M -$504.6M
YoY Change -27.43%
Common Stock $596.0K $575.0K
YoY Change 3.83%
Preferred Stock
YoY Change
Treasury Stock (at cost) $468.6M $467.3M
YoY Change 7.0%
Treasury Stock Shares 26.68M shares 26.57M shares
Shareholders Equity $196.8M $36.86M $29.31M
YoY Change
Total Liabilities & Shareholders Equity $1.215B $1.214B
YoY Change -12.48%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $109.8M -$145.0K -$272.0K
YoY Change -46.69%
Depreciation, Depletion And Amortization $35.60M $35.50M
YoY Change -64.93%
Cash From Operating Activities $58.20M $76.70M
YoY Change -60.44%
INVESTING ACTIVITIES
Capital Expenditures -$10.80M -$4.000M
YoY Change -46.27%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$10.70M -$4.000M
YoY Change -46.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -46.90M -72.50M
YoY Change -64.2%
NET CHANGE
Cash From Operating Activities 58.20M 76.70M
Cash From Investing Activities -10.70M -4.000M
Cash From Financing Activities -46.90M -72.50M
Net Change In Cash 600.0K 200.0K
YoY Change -115.0%
FREE CASH FLOW
Cash From Operating Activities $58.20M $76.70M
Capital Expenditures -$10.80M -$4.000M
Free Cash Flow $69.00M $80.70M
YoY Change -58.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001556739
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2018 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5555
CY2020Q3 us-gaap Defined Benefit Plan Type Extensible List
DefinedBenefitPlanTypeExtensibleList
us-gaap:PensionPlansDefinedBenefitMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35895
dei Entity Registrant Name
EntityRegistrantName
THRYV HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-2740040
dei Entity Address Address Line1
EntityAddressAddressLine1
2200 West Airfield Drive, P.O. Box 619810
dei Entity Address City Or Town
EntityAddressCityOrTown
D/FW Airport
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75261
dei City Area Code
CityAreaCode
(972)
dei Local Phone Number
LocalPhoneNumber
453-7000
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
THRY
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31028554 shares
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240325000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
319116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
862507000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1076244000 USD
CY2020Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
87347000 USD
CY2019Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
109588000 USD
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
278941000 USD
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
364873000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
60775000 USD
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
83730000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
201939000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
266643000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34176000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34352000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
116723000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
130727000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
35454000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
50471000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
110883000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
155285000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1184000 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
60000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
19414000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5059000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
218936000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
278201000 USD
us-gaap Costs And Expenses
CostsAndExpenses
727900000 USD
us-gaap Costs And Expenses
CostsAndExpenses
922587000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
21389000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
40915000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
134607000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
153657000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
11442000 USD
CY2019Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
17464000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
39648000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
51998000 USD
CY2020Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
4167000 USD
CY2019Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
6202000 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
13903000 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
19070000 USD
CY2020Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
30175000 USD
CY2019Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
16111000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
31312000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
19797000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6375000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24395000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1138000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49744000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56417000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-24250000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1410000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10323000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18860000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-145000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-272000 USD
us-gaap Net Income Loss
NetIncomeLoss
39421000 USD
us-gaap Net Income Loss
NetIncomeLoss
37557000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30857617 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33468556 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31621039 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43323602 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30857617 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33468556 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33990771 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46028655 shares
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1771000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1912000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34535000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26828000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
326240000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
369690000 USD
CY2020Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
404000 USD
CY2019Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss Current
ContractWithCustomerAssetAccumulatedAllowanceForCreditLossCurrent
0 USD
CY2020Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
12484000 USD
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
11682000 USD
CY2020Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
27818000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
37460000 USD
CY2020Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
11821000 USD
CY2019Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
15321000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18203000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12715000 USD
CY2020Q3 dxm Indemnification Asset Current
IndemnificationAssetCurrent
25911000 USD
CY2019Q4 dxm Indemnification Asset Current
IndemnificationAssetCurrent
29789000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
424248000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
478569000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86429000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
101512000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20015000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39046000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
609457000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
609457000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
60561000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
147480000 USD
CY2020Q3 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
2760000 USD
CY2019Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
3451000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10576000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8777000 USD
CY2020Q3 us-gaap Assets
Assets
1214046000 USD
CY2019Q4 us-gaap Assets
Assets
1388292000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
16215000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16067000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
165903000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
140261000 USD
CY2020Q3 dxm Financing Obligations Current
FinancingObligationsCurrent
698000 USD
CY2019Q4 dxm Financing Obligations Current
FinancingObligationsCurrent
580000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5947000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9579000 USD
CY2020Q3 us-gaap Interest Payable Current
InterestPayableCurrent
9899000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
13164000 USD
CY2020Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
32259000 USD
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
53111000 USD
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18769000 USD
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24679000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
249690000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
257441000 USD
CY2020Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
482000 USD
CY2019Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
593000 USD
CY2020Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
348528000 USD
CY2019Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
420036000 USD
CY2020Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
155600000 USD
CY2019Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
189371000 USD
CY2020Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
81641000 USD
CY2019Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
104985000 USD
CY2020Q3 dxm Financing Obligations Noncurrent
FinancingObligationsNoncurrent
55005000 USD
CY2019Q4 dxm Financing Obligations Noncurrent
FinancingObligationsNoncurrent
55537000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
198290000 USD
CY2019Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
193533000 USD
CY2020Q3 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
37661000 USD
CY2019Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
43026000 USD
CY2020Q3 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
10003000 USD
CY2019Q4 us-gaap Accrued Insurance Noncurrent
AccruedInsuranceNoncurrent
10874000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
12391000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
54738000 USD
CY2020Q3 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1911000 USD
CY2019Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
1833000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25848000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28783000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
623000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
875000 USD
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
927501000 USD
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1103591000 USD
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57469391 shares
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30903450 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57443282 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33490526 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
575000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
574000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1008243000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1008701000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
26565941 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
23952756 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
467331000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
437962000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-504632000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-544053000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
36855000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
27260000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1214046000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1388292000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
36500000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
444000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-145000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
36855000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
27725000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1880000 USD
CY2019Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
20000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-272000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
29313000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
27260000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
30626000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
356000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
444000 USD
us-gaap Net Income Loss
NetIncomeLoss
39421000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
36855000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
428340000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
437962000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1880000 USD
us-gaap Net Income Loss
NetIncomeLoss
37557000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
29313000 USD
us-gaap Net Income Loss
NetIncomeLoss
39421000 USD
us-gaap Net Income Loss
NetIncomeLoss
37557000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
110883000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
155285000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
801000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
856000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-42346000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-25517000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
27709000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21945000 USD
dxm Provision For Service Credits
ProvisionForServiceCredits
28268000 USD
dxm Provision For Service Credits
ProvisionForServiceCredits
20752000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
-4195000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9536000 USD
us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
31312000 USD
us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
19797000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6375000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3476000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5294000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
19414000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5059000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-3878000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-4646000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15742000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-51659000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
803000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
17030000 USD
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-1885000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-3500000 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-4105000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7285000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8822000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-81292000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-89270000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
36912000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
11217000 USD
dxm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-3998000 USD
dxm Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-7078000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5911000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3236000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-896000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-33901000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
174590000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
188144000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
13296000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1546000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
846000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
147000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15484000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12597000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
72629000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
108262000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
32761000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
48738000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
193625000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
225000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
868811000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
814672000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
892155000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
844586000 USD
dxm Repayments Of Financing Obligations
RepaymentsOfFinancingObligations
414000 USD
dxm Repayments Of Financing Obligations
RepaymentsOfFinancingObligations
946000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
774000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30626000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
437962000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
445000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
82000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
439000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-159247000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-207532000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-141000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31985000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1912000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34169000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1771000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2184000 USD
us-gaap Interest Paid Net
InterestPaidNet
56845000 USD
us-gaap Interest Paid Net
InterestPaidNet
58972000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15757000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
33159000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company’s condensed consolidated financial statements requires management to make estimates and assumptions about future events that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable. The results of those estimates form the basis for making judgments about the carrying values of certain assets and liabilities.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Examples of reported amounts that rely on significant estimates include revenue recognition, allowance for credit losses, capitalized costs to obtain a contract, certain amounts relating to the accounting for income taxes, indemnification asset, stock-based compensation liability, operating lease right-of-use assets and operating lease liabilities, accrued service credits, pension assets and pension obligations. Significant estimates are also used in determining the recoverability and fair value of fixed assets and capitalized software, operating lease right-of-use assets, goodwill, and intangible assets.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the novel strain of coronavirus, commonly referred to as COVID-19 (“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) pandemic and the uncertainty of the extent of the impacts related there to, many of the estimates and assumptions required increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, these estimates may materially change in future periods.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments subject to concentrations of credit risk consist primarily of trade receivables. The Company deposits cash on hand with major financial institutions. Cash balances at major financial institutions may exceed limits insured by the Federal Deposit Insurance Corporation.</span></div><div style="text-indent:13.5pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of revenue in all periods presented was derived from sales to local SMBs that operate in limited geographical areas. These SMBs are usually billed in monthly installments when the services begin and, in turn, make monthly payments, requiring the Company to extend credit to these clients. This practice is widely accepted within the industry. While most new SMBs and those wanting to expand their current media presence through the Company’s services are subject to a credit review, the default rates of SMBs are generally higher than those of larger companies. </span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining approximate </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of revenue in all periods presented was derived from the sale of marketing services to larger businesses that advertise regionally or nationally. Contracted certified marketing representatives (“CMRs”) purchase advertising on behalf of these businesses. Payment for advertising is due when the advertising is published and is received directly from the CMRs, net of the CMRs’ commission. The CMRs are responsible for billing and collecting from these businesses. While the Company still has exposure to credit risks, historically, the losses from this client set have been less than that of local SMBs.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its operations in the United States of America. No single directory or client accounted for more than 10% of the Company’s revenue for the three and nine months ended September 30, 2020 and 2019. Additionally, no single client accounted for more than 5% of the Company’s outstanding accounts receivable as of September 30, 2020 and December 31, 2019.</span></div>
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
16500000 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
2900000 USD
CY2020Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1200000 USD
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
5100000 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000 USD
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6200000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18500000 USD
CY2020Q3 dxm Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits
RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits
7800000 USD
dxm Revenue From Contract With Customer Excluding Assessed Tax Covid19 Credits
RevenueFromContractWithCustomerExcludingAssessedTaxCOVID19Credits
14200000 USD
CY2020Q3 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
500000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-3900000 USD
CY2019Q3 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-3700000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-4600000 USD
CY2020Q3 dxm Deferred Compensation And Unrecognized Share Based Arrangements Liability Fair Value Disclosure
DeferredCompensationAndUnrecognizedShareBasedArrangementsLiabilityFairValueDisclosure
47900000 USD
CY2020Q3 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
37700000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1300000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-4200000 USD
CY2019Q4 dxm Deferred Compensation And Unrecognized Share Based Arrangements Liability Fair Value Disclosure
DeferredCompensationAndUnrecognizedShareBasedArrangementsLiabilityFairValueDisclosure
60200000 USD
CY2019Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
43000000.0 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-4900000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9500000 USD
CY2019Q4 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
198900000 USD
CY2020Q3 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2019Q3 us-gaap Restructuring Charges
RestructuringCharges
8348000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Restructuring Charges
RestructuringCharges
36251000 USD
CY2020Q3 us-gaap Restructuring And Related Cost Cost Incurred To Date1
RestructuringAndRelatedCostCostIncurredToDate1
198912000 USD
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
15004000 USD
us-gaap Restructuring Charges
RestructuringCharges
0 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
11905000 USD
CY2020Q3 us-gaap Restructuring Reserve
RestructuringReserve
3099000 USD
CY2019Q4 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
26828000 USD
dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
27709000 USD
dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss Writeoff
AccountsReceivableAndContractWithCustomerAllowanceForCreditLossWriteoff
19598000 USD
CY2020Q3 dxm Accounts Receivable And Contract With Customer Allowance For Credit Loss
AccountsReceivableAndContractWithCustomerAllowanceForCreditLoss
34939000 USD
dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
27700000 USD
CY2020Q3 dxm Accounts Receivable And Contract With Customer Credit Loss Expense Reversal
AccountsReceivableAndContractWithCustomerCreditLossExpenseReversal
5300000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
34500000 USD
CY2020Q3 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
400000 USD
dxm Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19
AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19
2500000 USD
CY2020Q3 dxm Accounts Receivable Allowance For Credit Loss Incremental Increase Decrease Due To Covid19
AccountsReceivableAllowanceForCreditLossIncrementalIncreaseDecreaseDueToCOVID19
0 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
37642000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
43155000 USD
CY2020Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3709000 USD
CY2019Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
3377000 USD
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
69103000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
27232000 USD
CY2020Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47470000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
57474000 USD
CY2020Q3 dxm Accrued Service Credits Current
AccruedServiceCreditsCurrent
7979000 USD
CY2019Q4 dxm Accrued Service Credits Current
AccruedServiceCreditsCurrent
9023000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
165903000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
140261000 USD
CY2020Q3 us-gaap Severance Costs1
SeveranceCosts1
3300000 USD
us-gaap Severance Costs1
SeveranceCosts1
10600000 USD
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
41900000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
585769000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
714392000 USD
CY2020Q3 dxm Financing Obligations Noncash Residual Value Of Failed Sale Leaseback Transaction
FinancingObligationsNoncashResidualValueOfFailedSaleLeasebackTransaction
54676000 USD
CY2019Q4 dxm Financing Obligations Noncash Residual Value Of Failed Sale Leaseback Transaction
FinancingObligationsNoncashResidualValueOfFailedSaleLeasebackTransaction
54676000 USD
CY2020Q3 dxm Financing Obligations Minimum Lease Payments Failed Sale Leaseback Transaction
FinancingObligationsMinimumLeasePaymentsFailedSaleLeasebackTransaction
1027000 USD
CY2019Q4 dxm Financing Obligations Minimum Lease Payments Failed Sale Leaseback Transaction
FinancingObligationsMinimumLeasePaymentsFailedSaleLeasebackTransaction
1441000 USD
CY2020Q3 dxm Financing Obligations
FinancingObligations
55703000 USD
CY2019Q4 dxm Financing Obligations
FinancingObligations
56117000 USD
CY2020Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
3729000 USD
CY2019Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
5537000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
12162000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
16721000 USD
CY2020Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
4001000 USD
CY2019Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3761000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
12060000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
11259000 USD
CY2020Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-986000 USD
CY2019Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-719000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-1010000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-719000 USD
CY2020Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-29461000 USD
CY2019Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-13616000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-30200000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-13616000 USD
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
30175000 USD
CY2019Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
16111000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
31312000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
19797000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-1000000.0 USD
CY2020Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-1000000.0 USD
CY2019Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-700000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-700000 USD
CY2020Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-29500000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-30200000 USD
us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-13600000 USD
CY2019Q3 us-gaap Defined Benefit Plan Amortization Of Gains Losses
DefinedBenefitPlanAmortizationOfGainsLosses
-13600000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1000000.0 shares
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
12600000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9200000 USD
CY2020Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
800000 shares
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
8800000 USD
CY2019Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
24000000.0 shares
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
438000000.0 USD
CY2019Q2 dxm Payments Of Capital Distribution To Option Holders
PaymentsOfCapitalDistributionToOptionHolders
33900000 USD
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10500000 shares
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10500000 shares
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5800000 shares
CY2020Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
5800000 shares
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
24.39
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
24.39
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-145000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-272000 USD
us-gaap Net Income Loss
NetIncomeLoss
39421000 USD
us-gaap Net Income Loss
NetIncomeLoss
37557000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30857617 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33468556 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31621039 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43323602 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.87
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-145000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-272000 USD
us-gaap Net Income Loss
NetIncomeLoss
39421000 USD
us-gaap Net Income Loss
NetIncomeLoss
37557000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30857617 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33468556 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31621039 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43323602 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2369732 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2705053 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30857617 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33468556 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33990771 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46028655 shares
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.82
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.994
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.239
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.208
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.334
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
28200000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
48300000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
28200000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
48300000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
8500000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
10700000 USD
CY2020Q3 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
26600000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240325000 USD
CY2020Q3 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
69294000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
319116000 USD
CY2019Q3 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
98278000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
862507000 USD
dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
300208000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1076244000 USD
dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
358746000 USD
CY2020Q3 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
69294000 USD
CY2019Q3 dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
98278000 USD
dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
300208000 USD
dxm Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
358746000 USD
CY2020Q3 dxm Accounting Standards Update Lease Impact
AccountingStandardsUpdateLeaseImpact
0 USD
CY2019Q3 dxm Accounting Standards Update Lease Impact
AccountingStandardsUpdateLeaseImpact
62000 USD
dxm Accounting Standards Update Lease Impact
AccountingStandardsUpdateLeaseImpact
0 USD
dxm Accounting Standards Update Lease Impact
AccountingStandardsUpdateLeaseImpact
382000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
15609000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
23666000 USD
us-gaap Interest Expense
InterestExpense
53551000 USD
us-gaap Interest Expense
InterestExpense
71068000 USD
CY2020Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
35454000 USD
CY2019Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
50471000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
110883000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
155285000 USD
CY2020Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
30175000 USD
CY2019Q3 us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
16111000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
31312000 USD
us-gaap Net Periodic Defined Benefits Expense Reversal Of Expense Excluding Service Cost Component
NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
19797000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2019Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6375000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1184000 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
60000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
19414000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
5059000 USD
CY2020Q3 dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
6710000 USD
CY2019Q3 dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
8288000 USD
dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
23902000 USD
dxm Restructuring Charges And Integration Expenses
RestructuringChargesAndIntegrationExpenses
31192000 USD
CY2020Q3 dxm Transaction Costs
TransactionCosts
4913000 USD
CY2019Q3 dxm Transaction Costs
TransactionCosts
143000 USD
dxm Transaction Costs
TransactionCosts
14679000 USD
dxm Transaction Costs
TransactionCosts
143000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1289000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-4863000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-4195000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9536000 USD
CY2020Q3 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
540000 USD
CY2019Q3 dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-3736000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-3878000 USD
dxm Gain Loss On Remeasurement Of Indemnification Asset
GainLossOnRemeasurementOfIndemnificationAsset
-4646000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1105000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
410000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2960000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
390000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24395000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1138000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49744000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
56417000 USD
CY2020Q3 us-gaap Severance Costs1
SeveranceCosts1
3300000 USD
us-gaap Severance Costs1
SeveranceCosts1
10600000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
240325000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
319116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
862507000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1076244000 USD

Files In Submission

Name View Source Status
0001628280-20-016327-index-headers.html Edgar Link pending
0001628280-20-016327-index.html Edgar Link pending
0001628280-20-016327.txt Edgar Link pending
0001628280-20-016327-xbrl.zip Edgar Link pending
dxm-20200930.htm Edgar Link pending
dxm-20200930.xsd Edgar Link pending
dxm-20200930_cal.xml Edgar Link unprocessable
dxm-20200930_def.xml Edgar Link unprocessable
dxm-20200930_htm.xml Edgar Link completed
dxm-20200930_lab.xml Edgar Link unprocessable
dxm-20200930_pre.xml Edgar Link unprocessable
exhibit311-q32020.htm Edgar Link pending
exhibit312-q32020.htm Edgar Link pending
exhibit321-q32020.htm Edgar Link pending
exhibit322-q32020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thryv-arstockholdersagre.htm Edgar Link pending
thryv-arstockholdersagre001.jpg Edgar Link pending
thryv-arstockholdersagre002.jpg Edgar Link pending
thryv-arstockholdersagre003.jpg Edgar Link pending
thryv-arstockholdersagre004.jpg Edgar Link pending
thryv-arstockholdersagre005.jpg Edgar Link pending
thryv-arstockholdersagre006.jpg Edgar Link pending
thryv-arstockholdersagre007.jpg Edgar Link pending
thryv-arstockholdersagre008.jpg Edgar Link pending
thryv-arstockholdersagre009.jpg Edgar Link pending
thryv-arstockholdersagre010.jpg Edgar Link pending
thryv-arstockholdersagre011.jpg Edgar Link pending
thryv-arstockholdersagre012.jpg Edgar Link pending
thryv-arstockholdersagre013.jpg Edgar Link pending
thryv-arstockholdersagre014.jpg Edgar Link pending
thryv-arstockholdersagre015.jpg Edgar Link pending
thryv-arstockholdersagre016.jpg Edgar Link pending
thryv-arstockholdersagre017.jpg Edgar Link pending
thryv-arstockholdersagre018.jpg Edgar Link pending
thryv-arstockholdersagre019.jpg Edgar Link pending
thryv-arstockholdersagre020.jpg Edgar Link pending
thryv-arstockholdersagre021.jpg Edgar Link pending
thryv-arstockholdersagre022.jpg Edgar Link pending
thryv-arstockholdersagre023.jpg Edgar Link pending
thryv-arstockholdersagre024.jpg Edgar Link pending
thryv-arstockholdersagre025.jpg Edgar Link pending
thryv-arstockholdersagre026.jpg Edgar Link pending
thryv-arstockholdersagre027.jpg Edgar Link pending
thryv-arstockholdersagre028.jpg Edgar Link pending
thryv-arstockholdersagre029.jpg Edgar Link pending
thryv-arstockholdersagre030.jpg Edgar Link pending
thryv-arstockholdersagre031.jpg Edgar Link pending
thryv-arstockholdersagre032.jpg Edgar Link pending
thryv-arstockholdersagre033.jpg Edgar Link pending
thryv-arstockholdersagre034.jpg Edgar Link pending
thryv-arstockholdersagre035.jpg Edgar Link pending
thryv-arstockholdersagre036.jpg Edgar Link pending
thryv-arstockholdersagre037.jpg Edgar Link pending
thryv-arstockholdersagre038.jpg Edgar Link pending
thryv-arstockholdersagre039.jpg Edgar Link pending
thryv-arstockholdersagre040.jpg Edgar Link pending
thryv-arstockholdersagre041.jpg Edgar Link pending
thryv-arstockholdersagre042.jpg Edgar Link pending
thryv-arstockholdersagre043.jpg Edgar Link pending
thryv-arstockholdersagre044.jpg Edgar Link pending
thryv-arstockholdersagre045.jpg Edgar Link pending
thryv-arstockholdersagre046.jpg Edgar Link pending
thryv-arstockholdersagre047.jpg Edgar Link pending
thryv-arstockholdersagre048.jpg Edgar Link pending
thryv-arstockholdersagre049.jpg Edgar Link pending
thryv-arstockholdersagre050.jpg Edgar Link pending
thryv-arstockholdersagre051.jpg Edgar Link pending
thryv-arstockholdersagre052.jpg Edgar Link pending
thryv-arstockholdersagre053.jpg Edgar Link pending
thryv-arstockholdersagre054.jpg Edgar Link pending
thryv-arstockholdersagre055.jpg Edgar Link pending
thryv-arstockholdersagre056.jpg Edgar Link pending
thryv-arstockholdersagre057.jpg Edgar Link pending
thryv-arstockholdersagre058.jpg Edgar Link pending
thryv-arstockholdersagre059.jpg Edgar Link pending